Catherine A. Sohn Maze Therapeutics, Inc. (MAZE) insider trading activity

Shares Held (Direct Ownership) 0

n/a 3M change

n/a 12M change

Total Value Held N/A

Catherine A. Sohn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 07 2026	SELL Open market or private sale	$1,052,841 $39.11 p/Share	26,920 Reduced 100.0%	0 Common Stock
Jan 07 2026	BUY Exercise of conversion of derivative security	$280,506 $10.42 p/Share	26,920 Added 50.0%	26,920 Common Stock
Jan 06 2026	SELL Open market or private sale	$96,279 $38.62 p/Share	2,493 Reduced 100.0%	0 Common Stock
Jan 06 2026	BUY Exercise of conversion of derivative security	$25,977 $10.42 p/Share	2,493 Added 50.0%	2,493 Common Stock

JAZZ

Jazz Pharmaceuticals plc Healthcare

Director

ALT

Altimmune, Inc. Healthcare

LNDC

LANDEC CORP \CA\ Healthcare

Director

AXLA

Axcella Health Inc. Healthcare

Director

RUBY

Rubius Therapeutics, Inc. Healthcare

Director

CAS

Dublin 4, L2

Receive a notification when an Institution or Guru buys or sells MAZE shares.

Notify only if

Value

Get notified when an Maze Therapeutics, Inc. insider buys or sells MAZE shares.

Notify only if

Operation

Value

Type

Receive news related to Maze Therapeutics, Inc.